Nu Skin Enterprises (NUS) Hits New 12-Month High and Low at $75.82

Nu Skin Enterprises (NYSE:NUS) reached a new 52-week high and low during trading on Friday . The company traded as low as $75.82 and last traded at $74.32, with a volume of 95453 shares trading hands. The stock had previously closed at $75.05.

A number of equities research analysts recently commented on the stock. ValuEngine raised shares of Nu Skin Enterprises from a “buy” rating to a “strong-buy” rating in a research report on Monday, April 2nd. Zacks Investment Research cut shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Wednesday, February 28th. Deutsche Bank increased their target price on shares of Nu Skin Enterprises from $75.00 to $77.00 and gave the company a “buy” rating in a research report on Friday, February 16th. Stifel Nicolaus increased their target price on shares of Nu Skin Enterprises from $50.00 to $57.00 and gave the company a “sell” rating in a research report on Friday, February 16th. Finally, Pivotal Research reissued a “buy” rating and set a $90.00 target price on shares of Nu Skin Enterprises in a research report on Friday, February 16th. Two analysts have rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. Nu Skin Enterprises currently has a consensus rating of “Hold” and a consensus price target of $71.29.

How to Become a New Pot Stock Millionaire

The firm has a market capitalization of $3,958.89, a PE ratio of 22.63, a price-to-earnings-growth ratio of 2.09 and a beta of 1.36. The company has a current ratio of 1.74, a quick ratio of 1.17 and a debt-to-equity ratio of 0.44.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Thursday, February 15th. The company reported $1.20 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.19 by $0.01. The business had revenue of $666.20 million during the quarter, compared to analysts’ expectations of $667.39 million. Nu Skin Enterprises had a net margin of 5.68% and a return on equity of 25.23%. The business’s quarterly revenue was up 25.4% on a year-over-year basis. During the same quarter last year, the company posted $0.79 earnings per share. analysts predict that Nu Skin Enterprises will post 3.56 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 14th. Shareholders of record on Monday, February 26th were issued a $0.365 dividend. The ex-dividend date was Friday, February 23rd. This represents a $1.46 dividend on an annualized basis and a dividend yield of 2.00%. This is a boost from Nu Skin Enterprises’s previous quarterly dividend of $0.36. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 45.20%.

In related news, Chairman Steven Lund sold 81,000 shares of the firm’s stock in a transaction on Wednesday, April 4th. The shares were sold at an average price of $75.00, for a total transaction of $6,075,000.00. Following the completion of the transaction, the chairman now owns 4,769 shares of the company’s stock, valued at $357,675. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Pisano R. Thomas sold 15,000 shares of the firm’s stock in a transaction on Wednesday, March 7th. The stock was sold at an average price of $72.00, for a total transaction of $1,080,000.00. Following the transaction, the director now directly owns 47,437 shares of the company’s stock, valued at approximately $3,415,464. The disclosure for this sale can be found here. In the last ninety days, insiders sold 141,843 shares of company stock valued at $10,393,337. Corporate insiders own 5.20% of the company’s stock.

Institutional investors have recently modified their holdings of the stock. Wolverine Asset Management LLC raised its holdings in shares of Nu Skin Enterprises by 106.9% during the fourth quarter. Wolverine Asset Management LLC now owns 1,514 shares of the company’s stock worth $103,000 after purchasing an additional 23,378 shares during the last quarter. Cerebellum GP LLC purchased a new position in shares of Nu Skin Enterprises during the fourth quarter worth $124,000. Amundi Pioneer Asset Management Inc. purchased a new position in shares of Nu Skin Enterprises during the fourth quarter worth $192,000. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Nu Skin Enterprises by 38.6% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,082 shares of the company’s stock worth $210,000 after purchasing an additional 858 shares during the last quarter. Finally, Franklin Resources Inc. purchased a new position in shares of Nu Skin Enterprises during the fourth quarter worth $215,000. 76.48% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: This story was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another publication, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this story can be read at https://www.dispatchtribunal.com/2018/04/08/nu-skin-enterprises-nus-hits-new-12-month-high-and-low-at-75-82.html.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply